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Abstract
Background: One-tenth of France’s population is prescribed at least one antidepressant, primarily by General
Practitioners. The reasons for this high prescription rate remain unclear. One-third of these prescriptions may not
comply with clinical practice guidelines, and 20% are potentially unrelated to any psychiatric condition. Our aim
was to explore how GPs declare they use antidepressants in daily practice and understand their reasons for
prescribing them.
Method: Six focus groups including a total of 56 rural and urban GPs, with four interviews were performed. The
topic guide focused on reasons for prescribing antidepressants in various primary care situations.
Phenomenological analysis was performed by four researchers.
Results: Antidepressants were seen as useful and not harmful. Personal assessment based on experience and
feeling determined the GPs’ decisions rather than the use of scales. Twenty-four “non-psychiatric” conditions
possibly leading to prescription of antidepressants in primary care were found.
Conclusions: The GPs reported prescribing antidepressants for a wide range of conditions other than depression.
The GPs’ decision making process is difficult and complex. They seemed to prefer to focus on their difficulties in
diagnosing depression rather than on useless overtreatment. Instead of using the guidelines criteria to detect
potential cases of useful prescription, physicians tend to use their own tools based on gut feelings, knowledge of
the patient and contextual issues.
Background
According to the French health insurance system,
approximately 10% of the country’sp o p u l a t i o ni sr e i m -
bursed for at least one antidepressant (AD) [1,2].
Between 1980 and 2008, AD sales increased sevenfold,
from € 84 million to € 525 million [3]. Reports from the
national insurance system and the European Commis-
sion have confirmed these trends [4,5]. France’sc o n -
sumption of ADs ranks amongst the highest in the
European Union [5]. They are mainly prescribed by
General Practitioners (GPs) [6]. The reasons for this
high prescription rate by French GPs remain unclear.
According to the available data, this consumption is
supposed to be related to a higher rate of depressed
patients in France, an increase in the number of patients
treated for depression, and higher demand for medical
care [6,7]. Clinical practice guidelines in France officially
recommend using an AD for major depressive episodes
and for anxiety only when the condition has conse-
quences on the patient’s life [8]. Dysthymia, isolated
symptoms not fulfilling the DSM IV criteria, light or
moderate episodes, or those lasting less than 15 days
should not be treated by ADs. One-third of the pre-
scriptions (30-35%) probably do not comply with these
statements and 20% may not be related to any psychia-
tric evidence based on standardized questionnaires
[9,10]. Furthermore, the data are not homogeneous:
other studies have shown that in 85% of cases, the
patients treated with GP-prescribed antidepressants met
DSM-IV depression criteria [11]. The main indications
for ADs are major depressive episodes and anxiety dis-
orders. Other conditions, such as neuropathic pain, also
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any medium, provided the original work is properly cited.result in prescription [12], but some indications remain
controversial [13,14]. Similar trends have been noticed
in other countries [15,16]. The aim of this study was to
explore GPs’ viewpoints regarding their reasons for pre-
scribing antidepressants and to determine what indica-
tions they reported using them for in daily practice.
Methods
Participant recruitment procedure
Groups were chosen using a purposeful sampling
method. This study population was drawn from two dif-
ferent sources. Firstly, four focus groups (FG) were held
with GPs recruited from existing “quality circles”. These
GPs already knew each other from previous professional
training sessions based on the French “peer group” tech-
nique. In this technique one of the participants presents
to the group of GPs a structured analysis of patient files
with a specific medical condition (e.g. diabetes, medica-
tions for high blood pressure). The group analyses all of
the issues, decisions or potential improvements to the
care of the patient and provides feedback to the partici-
pant presenting the case. The dynamic interaction
amongst these group members enabled us to collect
reliable data on their actual practices. Secondly, we
o r g a n i z e dt w of o c u sg r o u p sw i t hl o c u mG P s .L o c u m
physicians could have a different, more critical point of
view on the diagnostic and therapeutic options of the
doctors they stand in for: They were taught about the
importance of the guidelines during their recent initial
medical training. All of the locums were replacing either
rural or urban GPs and not only private-practice GPs
(GP principals) involved in the peer groups. The option
of running FG with locums was chosen in order to dis-
close attitudes or facts that the initial prescriber may
have concealed. The first group of locums were invited
using purposeful sampling and the second by a local
association of locums. Four of the locum participants
were unable to take part in the focus group and were
invited for a semi-structured interview using the same
topic guide. All participants were sent an invitation by
the group leader, and also received a telephone call
informing them about the general subject of the focus
group session. The participants gave their informed con-
sent before participating. According to the rules of the
research centre, ethical approval was not necessary for
this study. Five focus groups were held in Normandy
(two in rural areas), and the other took place in a north-
ern suburb of Paris. Overall, six focus groups were held,
using a continuous process of collection and analysis.
We ensured that the focus groups included younger and
older, more experienced male and female private-prac-
tice GPs and locums from both urban and rural areas.
Data saturation was reached after 4 focus groups with
GP principals, and the second focus group with the
locums did not bring any additional material. Informa-
tion on participant profiles is detailed in the “results”
section.
Data collection
Q u a l i t a t i v ed a t aw e r ec o l l e c t e dt h r o u g hf o c u sg r o u p s
a n di n t e r v i e w sw i t hG P s .T h ef o c u sg r o u p sw e r ec o n -
ducted between November 2008 and April 2009. A
topic guide was created based on the existing literature
[17] and the researchers’ previous experiences [18]. The
interviews focused on the GPs’ experiences, circum-
stances, influences, justifications, and explanations, con-
cerning both the psychiatric and non-psychiatric
conditions for which the antidepressants were described.
Two trained moderators briefly explained the aim of the
study and led the focus groups, using a detailed topic
guide (table 1). The sessions began by assessing the dif-
ficulty of taking care of certain patients based on guide-
lines. The relevance of the GPs’ prescriptions was never
challenged. The participants were asked to share their
personal experiences in dealing with antidepressant
drugs. The moderator ensured that all issues were cov-
ered and that everyone participated. One researcher
observed the group members, without intervening, and
gathered information on nonverbal communication and
the interaction between the participants. Audio record-
ings of all of the focus groups were made, and these
recordings were later transcribed.
Analysis
A phenomenological approach was used. The first aim
of this approach was to gather material coming from
GPs personal experiences in their own real situations.
Secondly, the analysis focused on what doctors said
about themselves or their peers regarding their experi-
ences with prescribing ADs. We gathered information
on what the GPs said regarding the social, family and
professional situations of their patients and on how they
saw the prescription of ADs helping them to solve their
patients’ problems. The final aim was to identify the
background and disease conditions that influenced the
doctors’ decision to prescribe. QSR Nvivo 8.0 Software
was used to perform the analysis.
In practice, information on non-psychiatric diagnoses
and situations other than those based on guideline cri-
teria that lead to prescription of an antidepressant was
brought together. Firstly, the researchers listened to the
audio recordings and noted any emerging themes. Sec-
ondly, working on the written transcription, each
researcher created a code list without any pre-conceived
framework (open coding). These codes were shared and
discussed within the research team. Units of information
(codes on situations, e.g. diseases and social conditions)
and concepts (e.g. the doctor’s role, the doctor as a
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tion was examined and cross-analyzed with semantic
indicators of doubt, insistence and certainty. The code-
book was continuously revised, with the researchers
comparing all of the codes in the event of disagreement
and attempting to clarify their meaning, going back to
the context until mutual consent was reached. Following
an axial coding process, a matrix was developed in
order to highlight the GPs’ opinions about ADs in these
v a r i o u ss i t u a t i o n sa n dt of o c u so nt h ed e c i s i o n - m a k i n g
process.
Results
Participant profiles
The characteristics of the participants and practices are
summarized in table 2.
Key points
First of all, the expected usefulness of AD prescription
for several medical conditions is presented. Many condi-
tions result in prescription, which is seen as effective
but generally only with a symptomatic effect. Secondly,
the GPs’ options for assessing patients and situations are
presented. We will see how GPs cope with patient
demands, struggling through difficulties and inventing a
personal approach.
Usefulness of AD prescription (table 3)
ADs were seen as very useful, effective, safe and having
few adverse effects, which gave the GPs a sense of self-
confidence (Quote1). The GPs were not afraid to pre-
scribe antidepressants, which were seen as having little
or no risk of addiction and as not harmful (Quote 2).
Though antidepressants were sometimes assessed as
useless, (Quote3) they were very rarely related to suici-
dal intentions (Quote 4). In addition, the marketing of
new categories of antidepressants (SSRIs, SNRIs) was
seen as a major positive shift (Quote 5). According to
the GPs, antidepressants were appropriate for a wide
range of depression situations, from treating major
depressive episodes to preventing the deterioration of
moderate depressive conditions (Quote 6). They were
n o tc o n s i d e r e da su s e f u lf o re m e r g e n c i e s( Q u o t e7 ) .A t
the beginning of the focus groups, all of the GPs,
including the locums, agreed that antidepressants were
rarely prescribed in situations other than those specified
in the guidelines (Quote 8). The GPs expressed their
opinions on the excessive number of antidepressant pre-
scriptions by GPs, claiming that it was not malpractice
(Quote 9). The participants tried to defend themselves
against accusations of overprescribing antidepressants
and to justify the GP posture, protecting their patients
(Quote 10 & 11). In each focus group, the GPs debated
the idea that their prescriptions may be seen as ineffec-
tive. They also insisted on the difficulties of prescribing
antidepressants even though the patient was carefully
assessed. They questioned themselves whether or not
the depression was real, and whether or not prescribing
an AD was truly necessary (Quote 9). When asked to
explain their behaviour, the participants discussed sensi-
tive topics such as prescribing antidepressants without
any “real” diagnosis, or testing their diagnostic hypoth-
esis with the medication. They also expressed their
Table 1 Topic guide
Central focus To discover and understand actual prescription of antidepressants in general practice
Aim To explore the reasons for prescribing antidepressants in 2 main groups: in different settings
(primary care situations) and in different diagnoses (primary care conditions)
Instructions for the moderator
Beginning the focus group -Ice breaking question: “Primary care context and GPs’ expertise allow them to sometimes
justifiably prescribe drugs in situations other than those assessed using official criteria. Could
you tell us more about how you use ADs in primary care?
-Do not let the GPs repeat the guidelines or take the “official” stance
-Don’t be afraid to let them discuss strange or extreme situations
Questions about deciding on AD prescription
in primary care situations
-In your real practice, regarding prescription of ADs, how helpful are the major depression
criteria? (e.g. DSM IV)? How do you use official scales to assess patients? How do you manage
to decide in real life situations?
-Could you explain in what way the context (e.g. social, family, work) of the patient influences
your prescription?
-What is your opinion about the efficacy of ADs? Do you think GPs “anaesthetize” their patients
with ADs?
-Do you feel justified in prescribing ADs in situations that do not fit in with the official rules (e.g.
guidelines)? Could you explain why? How do you decide?
Questions about primary care conditions
leading to AD prescription
-Do you ever prescribe antidepressants when the patient is not depressed or anxious? Could
you explain your reasons for this?
-For what kind of conditions would you prescribe this way?
Examples for taking the discussion further -You often talk about “feeling”. Could you tell us more what you mean by this?
-Some of you talked about “real depression”. Could you clarify this concept?
-Locum physicians: What’s your opinion on the other GPs’ prescription of ADs?
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criteria when assessing their patients. We will see below
how GPs try to overcome these problems. Ending this
part of the focus group, despite the generally positive
assessments, most of the GPs insisted that these drugs
had only a palliative effect (Quotes 12 & 13).
Antidepressant therapy was sometimes compared to a
walking stick: the prescription by itself was not enough
to cure the patient.
Conditions (table 4)
Although the GPs initially stated that ADs were rarely
prescribed for other conditions than the guidelines [8],
Table 2 Characteristics of the 56 GPs interviewed for data collection
Physician characteristics
Range Mean
Age of GPs (n = 56) 25 to 65 40
Male/Female 39/17 69/31
Age of private practice GPs (n: 34) 27 to 65 53
Age of locum GPs (n = 22) 25 to 32 27.5
Number of years of practice (private practice GPs) (n = 34) 4t o3 5 2 0
Number of years of practice locum GPs (n = 22) <1 to 8 3.5
Practice characteristics
Number (n) Rate (%)
Urban practice 15 26
Rural practice 12 22
Urban & rural practice 28 50
Teacher or tutor 16 28
Particular interest (acupuncture, sports medicine) 2 3.5
Table 3 Usefulness of ADs
Quote
1
Self confidence “No difficulties to prescribe, I don’t’ find it difficult.. don’t ask myself any existential questions"(FG 4 Male GP, 50,
mixed practice)
Quote
2
Safe and secure “Antidepressants are useful, and change our patients’ lives completely ... They are safe drugs, with plenty of
indications, very little dependence, ...people can still work and drive”..."prescribing them only in characterized major
episodes, would be tragic for patients...” (FG 3, Male GP, 65, urban practice) “ Now we have the SSRI and there is
no problem handling the treatment"(FG 3 Male GP, 65, urban practice)
Quote
3
Useless “What is the real effect of the AD? Watchful waiting probably accounts for 50% of the success of the treatment,
(FG 5, Male GP, 27, locum)
Quote
4
Risk “I haven’t seen a suicide in 10 years. Before, it was terrifying” (FG 3, Male GP, 62, urban practice)
Quote
5
Major Shift “When you lived with those old drugs, this new period is absolutely fantastic"(FG 1 Male GP, 60, rural practice)
Quote
6
General use “ You can use them amongst young and old people, workers, unemployed, housewives, it would be a mistake not
to treat all of these moderate episodes, (FG 3 Male GP, 45, urban practice )
Quote
7
Emergencies Feeling it is an emergency situation will not have any influence on my AD prescription. It will have an impact on
my decision to call for an ambulance (FG2,Male GP, 50, rural practice)
Quote
8
Indications “...Seen non-conventional prescriptions? It’s never happened to me, I think it’s exactly the contrary; many more
patients should have an AD and they don’t have one” (Interview 1, Female, 28, locum GP)
Quote
9
Reality of (AD effect, of
depression)
He was so bad, and really improved a lot in 7 to 14 days, and of course you do know that is not only the “real”
effect of ADs (FG 6, Female, 26, locum GP)
Quote
10
GPs’ posture “Moral suffering is by no means trivial! Psychiatrists giving us advice about GPs over-prescribing ADs. You have to
laugh or else you cry"(FG 4, Male, 51, Mixed practice GP)
Quote
11
Defense “What they say is we prescribe ADs to get rid of our patients, not listen to them, and it’s exactly the contrary in
our real daily practice” (FG 2 female GP, 48, Rural practice)
Quote
12
Real effect “You always come back to the same question: are antidepressants going to solve the problem? Surely not...” (FG 2
female GP 45, mixed practice)
Quote
13
Hiding problems “You hide the problem with a Band-Aid
® - the antidepressant - and you’ll take it off after a while, saying “Oh,
you’re better now.” (FG2, female GP, rural practice)
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tions, possibly leading to prescription (Quotes 14 to 19).
Symptoms (e.g. insomnia), syndromes (e.g. restless legs
syndrome) or diseases (e.g. migraine) were encountered.
The first group of these conditions included “standard”
reasons. These are known as well recognized reasons for
prescribing ADs (e.g. neuropathic pain, enuresis). The
second group of conditions, less frequently described,
included specific, precise conditions such as impotence
or irritable bowel syndrome. Sometimes, they were the
main reason for prescribing an AD. The third group
included unexplained symptoms and chronic conditions
with repeated complaints. An important point is that all
of these medical situations were frequently combined
with psychological complaints. Nevertheless, physicians
felt that these symptoms were in and of themselves rea-
sons for prescribing an AD, and not only complaints
related to a major depressive episode.
Assessing the patients and the situations
Coping with the patients (Table 5)
Patient opinions were central to initiating the prescrip-
tion of antidepressants. Their initial request was usually
for “something to help”. Most of the GPs, including the
locums, said they usually tried to postpone prescribing
antidepressants by waiting and closely monitoring the
patient, almost always in tandem with drugs seen as
having little effect or a placebo effect (e.g. calcium, mag-
nesium, etc.) or anti-anxiety medications (Quote 20).
Some participants harshly criticized these options,
accusing such drugs of masking the problem. Psycholo-
gical therapy was seen as efficient but difficult to achieve
due to the lack of available psychotherapists, who were
seen as overworked. This therapeutic option was not
suitable for everybody; some patients refused psy-
chotherapy straightaway, soon tired of it after starting or
saw it as inconvenient when coping with work hours
and family commitments. On the whole, the physicians
claimed they had neither the skills nor the time to per-
form psychotherapy by themselves. Some of them
doubted the effectiveness of this kind of care, especially
when social problems were prominent. As well, the GPs
felt that this type of therapy was not really affordable
for patients. Other options, such as giving sick notes for
employees or hospitalization, were seen as short term
solutions, not solving the patients’ problems, and were
widely rejected by the doctors (Quote 21).
Coping with guideline criteria (Table 5)
All of the participants insisted on the difficulty of asses-
sing the symptoms. The GPs described a process com-
bining guidelines and personal criteria for cases of
major depression. The objective vision of the DSM-IV
criteria sometimes seemed appealing. This was especially
true when managing complex situations or in an educa-
tional context (Quote 22). Some GPs reported these cri-
teria could help to supportt h e i rd e c i s i o n .L o c u m
physicians said that using scales on a general basis
would ease the transmission of patient data to the pri-
mary-care GP they were replacing. Despite these few
positive comments, the scales and recommendations
Table 4 Conditions leading to prescription of an antidepressant by the GPs
Theme Conditions n = 24
Neurology or neurological
symptoms n = 8
Isolated sleeping disorder, dementia, neuropathic pain, migraines, stroke side effects, restless legs, diffuse pain,
Parkinson’s disease.
Quote 14 “I prescribe paroxetine because she has restless legs symptoms, and paresthesia ...” (FG 5, Male GP 27,
locum)
Rheumatology, Musculo- skeletal
symptoms n = 5
Fibromyalgia, lower back pain, sciatica, muscle or joint symptoms, tension headaches.
Quote 15 “Somebody who has been coming again and again for 6 months, always complaining about lower
back pain. You’ve tried everything, no improvement..I possibly prescribe an AD...” (FG 2 male GP, 42, rural practice)
General symptoms n = 4 Chronic patient, asthenia or fatigue, unexplained complaints, lack of observance among DT 2 patients.
Quote 16 “All specialists send your patient back to you, all examinations have been done, everybody tells you there
is “nothing”, “nothing to be done”“ (FG 4, male GP, 50, rural practice)
Dermatology n = 1 Chronic pruritis.
Gastroenterology n = 2 Gastrointestinal symptoms, irritable bowel syndrome.
Quote 17 “I’ve had a patient, the local professor in gastroenterology prescribed him a tricyclic agent, telling it was
excellent for him, and the symptoms improved a lot...” (FG 1; female GP, 49, rural practice)
Sexual problems n = 2 Male sexual dysfunctions/impotence, premature ejaculation.
Quote 18 “ I’ve discovered ADs can be prescribed for impotence problems” (FG 1, male GP 59, urban practice)
Urological symptoms n = 2 Nocturnal enuresis, urinary incontinence.
Quote 19 “I prescribe ADs among patients who have post surgical incontinence, and I’m not the only one who
does that. Many professors in urology do so, it’s brilliant..."(FG 3; male GP, 45, urban practice)
Mercier et al. BMC Family Practice 2011, 12:99
http://www.biomedcentral.com/1471-2296/12/99
Page 5 of 9were mostly criticized (Quote 23), and were considered
as irrelevant in decision-making. They did not help the
G P st oa s s e s se i t h e rt h ei n t e n s i t yo ft h ed e p r e s s i o no r
the usefulness of prescribing an antidepressant in real
situations (Quote 24). The GPs preferred a comprehen-
sive approach, based mainly on a patient’sh i s t o r y ,a s
they needed to know what was “real or not” (Quote 25).
The exact proportion of “truly” depressed patients was a
subject of debate. Patients were often perceived as weak,
with no clear threshold between normal reactions and
pathological symptoms. The way of seeking help differed
from one patient to another (Quote 26). They frequently
hid symptoms, and the researchers watching them dur-
ing the focus group sessions analyzed their difficulties in
assessing patients as being similar to playing “hide and-
seek”.
Finding solutions (Table 6)
The GPs struggled to overcome these shortcomings,
searching for things such as prolonged weakness, minor
symptoms (e.g. less appetite and insomnia) and multiple
repeated complaints or consultations with no clearly
identifiable medical reason. They also used their perso-
nal skills, basing their assessment on the patients’ family,
social and professional background. “Feeling”, (quote 27)
“experience”, (quote 28) and “knowledge of the patient”,
(quote 29) seemed to be related. “Feeling” was described
much more frequently than the other criteria, seen as
an internal warning or a positive intuition. This “gut
feeling” was clearly different from experience, which was
related to years of medical practice. It was a quick judg-
ment rather than a slow, meticulous compilation of
“mini criteria”. “Being familiar with the patient” was
related to the quality of the relationship between the GP
and his patient, and was more of a means to assess their
personal history and the intensity of their depression
symptoms (Quote 30). As a result, working with new or
little-known patients proved unsettling for the GPs and
locum physicians, who felt ill at ease with their own
Table 5 Assessing the patients and the situations
Coping with the patients
Quote
20
Postponing the
prescription
“Patients ask for something to get better, but I don’t hear this as a request for an antidepressant, but it’s difficult not to
write down any prescription. Sometimes, I struggle with using “minor drugs” saying “Don’t worry, it’s not an
antidepressant.” (FG 2, female GP; 40, mixed practice)
Quote
21
“We do not have so many answers, feeling helpless with psychotherapy, and after that, there is only the sick note,
which is not really what they are asking for"(FG 4 female GP, 41, mixed practice)
Coping with official criteria
Quote
22
“When the patient has different signs, such as chronic pain, lower back pain, polymyalgia, it could be useful to deal
with these issues using scales, to make the patient understand he is really in a bad situation."(Interview 3, male GP, 30,
locum)
Quote23 “Scales are just great, scores are just great, but like you all just said: you don’t use them. This kind of medicine is exactly
the type we don’t want to practice!"(FG 3, male GP, 59, urban practice)
Quote24 Usefulness of scales When deciding what to do with a depressed patient, if I test him with a scale and there is just one point missing, I
won’t tell him: “Go back home, you’re not depressed."(FG3, male GP, 50, urban practice)
Quote
25
“Some people come because they constantly feel bad, these symptoms have been with them for a long, long time. It’s
so complicated, there is not a real depressive episode but you can call this masked depression."(FG 4 male GP, 40, mixed
practice)
Quote
26
“Those who work in health services, they always wait until the last minute”...or “they want a drug and a month later
they say “Dr. I stopped”... “the main obstacle to treatment is the patient himself” ... “They don’t want a sick note, they
say they have to go to work."(FG 1, female GP, 49, rural practice)
Table 6 Finding solutions
Quote
27
Feeling “I feel I am able to identify him in the waiting room” (FG 2, male GP, 40, rural practice)
Quote
28
Physician Experience “Our strength is our experience, which allows us to quickly diagnose, ultimately with only a few mistakes.” (FG 3,
male GP, 59, urban practice)
Quote
29
Knowledge of the patient “I have a different threshold for my prescription if I know the patient.” (FG 6, female GP, 29, locum)
Quote
30
Contact with the patient “I think it depends on the relationship. A patient who is at the end of his tether and says something about it
worries me less than one who keeps quiet."(FG4 female GP, 50, mixed practice)
Quote
31
Test diagnoses “It’s a kind of therapeutic trial: Sometimes, I get fooled. I see the patient a month later and they are doing really
well. They tell me, “Hey, I stopped taking that medication.” I tell myself, “If they stopped after just one month then it
really wasn’t a major depression."(FG1, male GP, 59, mixed practice)
Quote
32
Calling, seeing the
patient again
“I’ll call him back within 8 or 10 days to be certain of my diagnosis.”“ If the symptoms remain, and the patient
comes back it is possible to prescribe ADs “(FG 1, male GP, 35, rural practice)
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experienced GPs made a faster assessment. On the
other hand, the GPs also felt that too much trust in
these three components could be a pitfall leading to
mistaken judgment. They sometimes used a procedure
that involved giving a first prescription as a test (Quote
31) and then assessing the patient a few days later in
order to check their initial feelings. This was easily done
with elderly persons and with those in complex situa-
tions or having undefined symptoms (Quote 32). Doubts
about the validity of this “test” were expressed.
Discussion
This study resulted in two main key findings. The first
was the GPs’ prescription in numerous medical condi-
tions not including strictly psychiatric conditions.
Although we encountered AD prescription related to
well-defined diseases, “combined situations” with variable
combinations of physical symptoms and psychological
distress were the more standard situations leading to pre-
scription. It is already known that more than 90% of
depressed patients suffer from another physical or mental
disorder [19]. Although “standard causes” (e.g. depression
and anxiety) were the main reasons to prescribe, the
decision whether or not to prescribe was very difficult to
make. Our data suggest that the GPs tried to circumvent
their difficulties by developing their own tools.
The second main finding, clearly related to the first
one, was a consensus on the inadequacy of the guidelines
as a tool to help physicians decide whom to treat with
antidepressants. The GPs developed specific skills to
come up with their own personal “scales”, usually based
on an implicit combination of “gut feeling”, “knowledge
of the patient”,a n d“small signs”. This way of assessing
patients has already been described [20,21]. In case of
doubt, uncertainty could be diminished using the drug as
a “therapeutic test”. GPs also made their decision based
on information about difficulties in the patients’ social,
professional and family lives, fatigue and repeated, unex-
plained requests for medical care. This way of coping
with uncertainty is a strategy specific to GPs [20].
Though our GPs developed a strategy, no clear threshold
for making the decision to prescribe an antidepressant
was identified. This decision was clearly affected by the
GPs’ opinions on antidepressants, which were seen as
useful drugs with no major adverse effects. The decision
to prescribe was also influenced by patient’s background
and history, as well as by a lack of available psychothera-
peutic options. In this context, a GP could view prescrip-
tion of an antidepressant as “justified”, even though the
scale-based criteria were not met.
Our results reflected the basics of medical decision-
making: combining necessity, effectiveness, safety and
economy [22]. For the GPs in our sample, “necessity”
meant focusing mainly on lack of recognition of depres-
sive symptoms and under treatment, rather than useless
or ineffective overtreatment. Effectiveness was seen as
one of the main characteristics of antidepressants, even
though the lack of practical studies in real prescribing
situations has already been pointed out. Another main
finding was related to the safety of antidepressants.
Compared to psychological care, economy was a con-
cern for GPs. The overall combination of these 4 factors
could lead to a high antidepressant prescription rate.
Strengths and limitations
Several points support these findings. Firstly, all of the
GPs harshly criticized the guideline criteria and agreed
they were irrelevant in primary care settings, thus clearly
and explicitly assuming responsibility for the nature of
their actual practices. From this point of view, the
study’s phenomenological approach was successful: the
GPs recounted their true-life experiences with prescrib-
ing ADs, and the analysis was based on these experi-
ences, not on general opinions. This was facilitated by a
comprehensive approach: the participating GPs did
know that this study was being conducted by GP
researchers. This option was chosen in order to ensure
the GPs that they would not be judged by psychiatrists:
otherwise, the GPs may not have discussed their choices
and difficulties so freely. Secondly, a wide variety of
diagnoses, in addition to psychiatric conditions, were
assessed. This leads us to believe that the GPs talked
very freely about their real problems, even though this
study was based on related behaviours. Finally, and
despite the fact that they were younger and less experi-
enced, the locums mostly shared the same opinions. We
clearly made this choice in order to try to discover bor-
derline therapeutic choices among GPs who would have
declined the invitation to take part in a focus group on
the sensitive topic of AD prescription. None of the
locums recounted unexplained prescription of ADs. The
choice to use a sample composed of both urban and
rural GPs was also made to try to discover behaviours
and difficulties related to overbooked practices or a vari-
ety of patient situations. No clear differences in their
approach or behaviour appeared during the data analy-
sis. This was the case for both younger and older, more
experienced male and female GPs. This strengthens the
hypothesis that our outcomes are on the whole related
to primary care situations, and not only to certain prac-
tice characteristics.
Conducting focus groups on this sensitive subject
could have proven to be a limitation, hiding relevant
material: the GPs could have chosen to conceal odd pre-
scriptions or decisions not covered by validated scale
criteria. Nevertheless, the options chosen for the sample
could not have selected doctors very interested in this
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psychiatric conditions. Another limitation is the need
for more insight on the exact usefulness of the GP’s per-
sonal way of assessing a patient: feelings and knowledge
are well known in primary care, but we did not collect
any relevant material on the way the GPs made them
part of their decision-making process. One key finding
was that the GPs used a personal scale, but that no data
were collected to evaluate the actual performances of
these scales. No evidence was gathered concerning a
threshold, determined using these skills, after which an
antidepressant is prescribed. Our study was not designed
to explore these aspects in detail. The outcomes enable
us only to make hypothesis on GPs’ possibly prescribing
more than necessary, and not to focus on a particular
explanation. It is already well known that the positive
predictive value for routine diagnosis of depression is
low [18]. Could GP assessments using these personal
tools increase this rate?
Relevance for practice and future research
Another finding concerned GPs’ doubts regarding the
usefulness of guideline depression scales in primary care
settings. In our study, we saw GPs reinventing criteria.
This is consistent with other studies, showing that phy-
sicians’ familiarity with a patient was an important con-
dition in recognizing and managing depression [23]. If
physicians do not see these tools as useful and do not
use them at all, we should perhaps draw some conclu-
sions: instead of making every effort to generalize the
use of these tools, shouldn’t we assess what is currently
used in real practice? Such an assessment would likely
result in practices that were more often used in every-
day primary care settings. The relevance of antidepres-
sant treatment in non-psychiatric situations in primary
care seems to be a key question amongst many
researchers. Various studies and trials have tested the
usefulness of antidepressant drugs in “non-psychiatric”
situations [24,25]. As regards primary care, the external
validity of these studies is controversial, as primary care
rarely involves one clear condition, but rather combines
a wide variety of physical symptoms, psychological dis-
tresses and social issues. The usefulness of antidepres-
sant treatment in various primary care settings needs to
be comprehensively assessed. Prescribing fewer drugs
should be considered along with making counselling
and psychotherapy more available. The next step is to
try and understand decision making in real settings by
collecting data on antidepressant prescriptions from
patient records.
Conclusions
This study found 24 “non-psychiatric” conditions for
prescribing an antidepressant in primary care and
enabled a better understanding of the GPs’ decision-
making process. The guideline criteria officially designed
to help physicians during everyday practice were found
to be ineffective, thus leading the physicians to invent
their own tools, to detect potential cases of depression
based on their own feelings and to found their assess-
ment of the patient on knowledge and experience.
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